Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sangamo raising $51.6 million to fund zinc finger DNA-binding proteins programme

This article was originally published in Scrip

Executive Summary

Sangamo BioSciences has announced the pricing of its public offering of 6.7 million shares at a price of $7.70 per share, bringing in approximately $51.6 million. The shares were priced at a 7.9% discount to the 7 April closing share price of $8.36. Barclays Capital led the offering, and Sangamo has granted the underwriter an option to purchase an additional 1,005,000 shares.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC012529

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel